tiprankstipranks
PureTech Health PLC (GB:PRTC)
LSE:PRTC
UK Market
PRTC
PureTech Health
RESEARCH TOOLSreports
Want to see GB:PRTC full AI Analyst Report?

PureTech Health (PRTC) Ratios

25 Followers

PureTech Health Ratios

GB:PRTC's free cash flow for Q4 2025 was $0.41. For the 2025 fiscal year, GB:PRTC's free cash flow was decreased by $ and operating cash flow was $-18.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.59 6.59 9.33 6.76 3.99
Quick Ratio
 6.59 6.59 9.33 6.76 3.99
Cash Ratio
 5.49 5.49 6.78 3.72 1.55
Solvency Ratio
 -0.46 -0.47 0.29 -0.26 -0.27
Operating Cash Flow Ratio
 -1.83 -1.88 -3.25 -2.06 -1.85
Short-Term Operating Cash Flow Coverage
 -9.78 -10.02 -32.69 -28.63 -23.84
Net Current Asset Value
$ 75.98M$ 76.01M$ 191.55M$ 111.46M$ 231.13M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.26 0.04 0.07
Debt-to-Equity Ratio
 0.06 0.06 0.38 0.05 0.09
Debt-to-Capital Ratio
 0.06 0.06 0.28 0.05 0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.25 0.00 0.02
Financial Leverage Ratio
 1.71 1.71 1.45 1.50 1.30
Debt Service Coverage Ratio
 -1.73 -1.74 2.93 -2.80 -2.11
Interest Coverage Ratio
 -2.16 -2.15 -13.56 -10.84 -50.04
Debt to Market Cap
 0.02 0.02 0.28 <0.01 0.02
Interest Debt Per Share
 27.09 0.28 0.63 0.14 0.18
Net Debt to EBITDA
 2.47 2.41 -3.25 9.37 1.29
Profitability Margins
Gross Profit Margin
-471.15%28.14%100.00%-12387.33%-6546.17%
EBIT Margin
-2115.43%-2114.72%783.57%-3015.33%-4250.24%
EBITDA Margin
-2043.54%-2042.86%866.33%-2357.47%-3824.74%
Operating Profit Margin
-2115.41%-2114.72%-3154.00%-19493.20%-9464.45%
Pretax Profit Margin
-2380.86%-2380.90%550.96%-4813.73%-4439.38%
Net Profit Margin
-2355.50%-2355.42%1240.09%-8759.60%-2409.28%
Continuous Operations Profit Margin
-2362.91%-2362.83%643.85%-8883.73%-1773.44%
Net Income Per EBT
98.93%98.93%225.08%181.97%54.27%
EBT Per EBIT
112.55%112.59%-17.47%24.69%46.91%
Return on Assets (ROA)
-20.48%-20.95%8.88%-9.47%-7.17%
Return on Equity (ROE)
-31.83%-35.89%12.90%-14.16%-9.29%
Return on Capital Employed (ROCE)
-20.13%-20.59%-24.25%-22.75%-32.65%
Return on Invested Capital (ROIC)
-19.63%-20.08%-23.92%-22.50%-12.78%
Return on Tangible Assets
-20.50%-20.97%8.89%-9.48%-7.17%
Earnings Yield
-267.33%-27.67%10.56%-9.71%-5.59%
Efficiency Ratios
Receivables Turnover
 0.57 0.58 0.33 0.32 0.17
Payables Turnover
 8.65 1.11 0.00 6.40 5.75
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.40 0.41 0.29 0.04 0.06
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
 0.02 0.02 0.01 <0.01 <0.01
Cash Conversion Cycle
 596.17 296.13 1.09K 1.10K 2.09K
Days of Sales Outstanding
 638.37 624.07 1.09K 1.16K 2.15K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 42.21 327.93 0.00 57.04 63.46
Operating Cycle
 638.37 624.07 1.09K 1.16K 2.15K
Cash Flow Ratios
Operating Cash Flow Per Share
 -35.14 -0.36 -0.50 -0.39 -0.64
Free Cash Flow Per Share
 -35.14 -0.36 -0.50 -0.39 -0.65
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 -14.18K -14.18K -12.22K -432.31 -82.17
Capital Expenditure Coverage Ratio
 -14.18K -14.18K -12.22K -432.31 -82.17
Operating Cash Flow Coverage Ratio
 -4.29 -4.40 -0.84 -4.18 -3.81
Operating Cash Flow to Sales Ratio
 -18.25 -18.27 -31.14 -141.22 -85.55
Free Cash Flow Yield
-20.53%-21.46%-26.52%-15.69%-20.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.37 -3.61 9.47 -10.30 -17.89
Price-to-Sales (P/S) Ratio
 88.86 85.14 117.44 902.30 431.11
Price-to-Book (P/B) Ratio
 0.13 1.30 1.22 1.46 1.66
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.87 -4.66 -3.77 -6.37 -4.98
Price-to-Operating Cash Flow Ratio
 -0.48 -4.66 -3.77 -6.39 -5.04
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.01 -0.05 -0.31 1.25
Price-to-Fair Value
 0.13 1.30 1.22 1.46 1.66
Enterprise Value Multiple
 -1.88 -1.76 10.31 -28.90 -9.98
Enterprise Value
 178.77M 170.59M 385.24M 510.99M 798.02M
EV to EBITDA
 -1.88 -1.76 10.31 -28.90 -9.98
EV to Sales
 38.46 35.86 89.28 681.32 381.83
EV to Free Cash Flow
 -2.11 -1.96 -2.87 -4.81 -4.41
EV to Operating Cash Flow
 -2.11 -1.96 -2.87 -4.82 -4.46
Tangible Book Value Per Share
 126.40 1.27 1.51 1.67 1.95
Shareholders’ Equity Per Share
 129.30 1.30 1.54 1.70 1.94
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 -0.17 -0.85 0.60
Revenue Per Share
 1.93 0.02 0.02 <0.01 <0.01
Net Income Per Share
 -45.37 -0.47 0.20 -0.24 -0.18
Tax Burden
 0.99 0.99 2.25 1.82 0.54
Interest Burden
 1.13 1.13 0.70 1.60 1.04
Research & Development to Revenue
 12.14 12.14 12.58 128.31 55.56
SG&A to Revenue
 9.66 9.29 6.37 33.57 17.07
Stock-Based Compensation to Revenue
 0.00 0.00 5.30 5.89 7.03
Income Quality
 0.77 0.78 -4.84 1.59 4.82
Currency in USD